The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Preactivated Peripheral Blood Monocytes in Patients With Essential Hypertension
Open accessAbstract
Abstract —The purpose of this study was to investigate the possible involvement of human peripheral blood monocytes in the pathology of hypertensive disease. We determined the in vitro secretion patterns of proinflammatory cytokines obtained from isolated peripheral monocytes from normal controls and from hypertensive patients either after in vitro stimulation with angiotensin II (Ang II) with or without preincubation with an Ang II type 1 receptor antagonist (losartan) or after stimulation with lipopolysaccharide. Blood samples were obtained from 22 patients with essential hypertension (before any drug administration or after interruption of antihypertensive therapy) and from 24 normotensive healthy individuals used as a control group. Peripheral blood monocytes were isolated by density gradient centrifugation and plastic adherence. The state of monocyte activity was determined by the capacity to secrete tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and interleukin-6, (IL-6) either spontaneously or after stimulation. Cytokine concentrations were determined in culture supernatants by specific ELISA. Proinflammatory cytokine levels were assessed by semiquantitative reverse transcribed polymerase chain reaction. After stimulation with Ang II, the IL-1β secretion of peripheral blood monocytes was significantly increased in hypertensive patients versus healthy individuals ( P <0.05). In contrast, in monocytes preincubated with losartan before exposure to Ang II, IL-1β secretion was diminished in both groups to comparable levels. The secretion of IL-1β and TNF-α was significantly increased in peripheral blood monocytes from hypertensive patients versus healthy individuals after stimulation with lipopolysaccharide (TNF-α, P <0.02; IL-1β, P <0.05). Upregulation of IL-1β and TNF-α secretion in peripheral blood monocytes from hypertensive patients was also seen at the RNA level. Our results indicate preactivated peripheral blood monocytes in hypertensive patients. Ang II may be directly involved in the process of monocyte activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“water retention hormones such as angiotensin II have proinflammatory activities [37].”
From Evolutionary medicine and chronic inflammatory state—known and new concepts in pathophysiology (2012) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1006/abio.1987.9999 · Cited by 65,515
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,618
Fitzgerald, M., Hayward, I. P., Thomas, A. C., Campbell, J. H., & CAMPBELL, G. R. (1995) · Cited by 2,552
Boring, L., Gosling, J., Cleary, M., & Charo, I. F. (1998) · Nature · doi:10.1038/29788 · Cited by 1,965
Activation of Interleukin-6 Gene Expression through the NF-κB Transcription Factor
Libermann, T. A., & Baltimore, D. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.5.2327 · Cited by 1,403
Bevilacqua, M. P., Pober, J. S., Majeau, G. R., Fiers, W. C., Cotran, R. S., & Gimbrone, M. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4533 · Cited by 1,059
Alderman, M. H., Madhavan, S., Ooi, W. L., Cohen, H. W., Sealey, J. E., & Laragh, J. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104183241605 · Cited by 722
Is atherosclerosis an immunologically mediated disease?
Wick, G., Schett, G. A., Amberger, A., Kleindienst, R., & Xu, Q. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80067-0 · Cited by 398
Jelinek, D. F., & Lipsky, P. E. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.9.2970 · Cited by 208
Discrimination of viable and non‐viable cells using propidium iodide in two color immunofluorescence
Sasaki, D. T., Dumas, S. E., & Engleman, E. G. (1987) · Cytometry · doi:10.1002/cyto.990080411 · Cited by 185
Flagged first, then by citations
Cited by
Sorted by citations
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Tedgui, A., & Mallat, Z. (2006) · Physiological Reviews · doi:10.1152/physrev.00024.2005 · Cited by 1,751
Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome
Fernández-Real, J. M., & Ricart, W. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0010 · Cited by 886
Age-related inflammatory cytokines and disease
Brüünsgaard, H., & Pedersen, B. K. (2003) · Immunology and Allergy Clinics of North America · doi:10.1016/s0889-8561(02)00056-5 · Cited by 608
Inflammation and Infections as Risk Factors for Ischemic Stroke
Lindsberg, P. J., & Grau, A. (2003) · Stroke · doi:10.1161/01.str.0000089015.51603.cc · Cited by 519
Mechanisms of Disease: oxidative stress and inflammation in the pathogenesis of hypertension
Vaziri, N. D., & Rodríguez-Iturbe, B. (2006) · Nature Clinical Practice Nephrology · doi:10.1038/ncpneph0283 · Cited by 442
Immune mechanisms of hypertension
Drummond, G. R., Vinh, A., Guzik, T. J., & Sobey, C. G. (2019) · Nature reviews. Immunology · doi:10.1038/s41577-019-0160-5 · Cited by 447
Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney
Ruiz‐Ortega, M., Rupérez, M., Lorenzo, Ó., Esteban, V., Blanco, J., Mezzano, S. A., & Egido, J. (2002) · Kidney International · doi:10.1046/j.1523-1755.62.s82.4.x · Cited by 420
Proinflammatory actions of angiotensins
Ruiz-Ortega, M., Lorenzo, O., Suzuki, Y., Rupérez, M., & Egido, J. (2001) · Current Opinion in Nephrology and Hypertension · doi:10.1097/00041552-200105000-00005 · Cited by 412
Role of the Immune System in Hypertension
Rodríguez‐Iturbe, B., Pons, H., & Johnson, R. J. (2017) · Physiological Reviews · doi:10.1152/physrev.00031.2016 · Cited by 398
Ott, S. J., El Mokhtari, N. E., Musfeldt, M., Hellmig, S., Freitag, S., Rehman, A., Kühbacher, T., Nikolaus, S., Namsolleck, P., Blaut, M., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.579979 · Cited by 391
Self-citationFurman, D., Chang, J., Lartigue, L., Bolen, C. R., Haddad, F., Gaudilliere, B., Ganio, E. A., Fragiadakis, G. K., Spitzer, M. H., Douchet, I., et al. (2017) · Nature Medicine · doi:10.1038/nm.4267 · Cited by 389
Frąk, W., Wojtasińska, A., Lisińska, W., Młynarska, E., Franczyk, B., & Rysz, J. (2022) · Biomedicines · doi:10.3390/biomedicines10081938 · Cited by 284
Insulin Resistance the Hinge Between Hypertension and Type 2 Diabetes
Mancusi, C., Izzo, R., Gioia, G. D., Losi, M. A., Barbato, E., & Morisco, C. (2020) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-020-00408-8 · Cited by 232
Oxenkrug, G. F. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05356.x · Cited by 223
Navarro‐González, J. F., Milena, F. J., Fernández, C. M., León, C., & Garcı́a, J. G. (2006) · American Journal of Nephrology · doi:10.1159/000098004 · Cited by 220
Madhur, M. S., Elijovich, F., Alexander, M. R., Pitzer, A. L., Ishimwe, J., Beusecum, J. P. V., Patrick, D. M., Smart, C. D., Kleyman, T. R., Kingery, J. R., et al. (2021) · Circulation Research · doi:10.1161/circresaha.121.318052 · Cited by 218
IL ‐1β and IL ‐18: inflammatory markers or mediators of hypertension?
Krishnan, S. M., Sobey, C. G., Latz, E., Mansell, A. S., & Drummond, G. R. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12876 · Cited by 219
AbdAlla, S., Lother, H., Langer, A., el Faramawy, Y., & Quitterer, U. (2004) · Cell · doi:10.1016/j.cell.2004.10.006 · Cited by 204
Bautista, L. E. (2003) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001537 · Cited by 200
The underlying mechanisms for development of hypertension in the metabolic syndrome
Yanai, H., Tomono, Y., Ito, K., Furutani, N., Yoshida, H., & Tada, N. (2008) · Nutrition Journal · doi:10.1186/1475-2891-7-10 · Cited by 171
Is Hypertension an Inflammatory Process?
Boos, C., & Lip, G. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206776843313 · Cited by 165
Wenzel, P., Kossmann, S., Münzel, T. F., & Daiber, A. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.01.027 · Cited by 161
Renal and vascular hypertension-induced inflammation: role of angiotensin II
Ruiz‐Ortega, M., Esteban, V., Rupérez, M., Sánchez‐López, E., Rodríguez‐Vita, J., Carvajal, G., & Egido, J. (2006) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000203190.34643.d4 · Cited by 155
Microglia and Monocyte-Derived Macrophages in Stroke
Kim, E., & Cho, S. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0463-1 · Cited by 159
The Role of Inflammasome-Dependent and Inflammasome-Independent NLRP3 in the Kidney
Kim, Y., Kim, S., Kim, K., Lee, S.-H., & Moon, J.-Y. (2019) · Cells · doi:10.3390/cells8111389 · Cited by 157
Navarro‐González, J. F., Milena, F. F., Mora, C., León, C., Claveríe‐Martín, F., Flores, C. G., & Garcı́a, J. G. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.09918.x · Cited by 145
The role of inflammation in hypertension: novel concepts
Patrick, D. M., Beusecum, J. P. V., & Kirabo, A. (2020) · Current Opinion in Physiology · doi:10.1016/j.cophys.2020.09.016 · Cited by 140
Causal link between oxidative stress, inflammation, and hypertension.
Vaziri, N. D. (2008) · Iranian Journal of Kidney Diseases · Cited by 134
Activation of Peripheral Blood CD14+ Monocytes Occurs in Diabetes
Cipolletta, C., Ryan, K., Hanna, E., & Trimble, E. R. (2005) · Diabetes · doi:10.2337/diabetes.54.9.2779 · Cited by 128
The role of sodium in modulating immune cell function
Wilck, N., Balogh, A., Markó, L., Bartolomaeus, H., & Müller, D. N. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0167-y · Cited by 129
The association between metabolic syndrome components and the development of atherosclerosis
Aboonabi, A., Meyer, R. R., & Singh, I. (2019) · Journal of Human Hypertension · doi:10.1038/s41371-019-0273-0 · Cited by 125
Salt, Hypertension, and Immunity
Rucker, A. J., Rudemiller, N. P., & Crowley, S. D. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021317-121134 · Cited by 123
The role of macrophages in hypertension and its complications
Rucker, A. J., & Crowley, S. D. (2017) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-017-1950-x · Cited by 118
Nomura, S., Kanazawa, S., & Fukuhara, S. (2002) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001447 · Cited by 106
Evolutionary medicine and chronic inflammatory state—known and new concepts in pathophysiology
Straub, R. H. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0861-8 · Cited by 105
Angiotensin II Induces Migration and Pyk2/Paxillin Phosphorylation of Human Monocytes
Kintscher, U., Wakino, S., Kim, S., Fleck, E., Hsueh, W. A., & Law, R. E. (2001) · Hypertension · doi:10.1161/01.hyp.37.2.587 · Cited by 105
Cancer, inflammation and the AT1 and AT2 receptors.
Smith, G. R., & Missailidis, S. (2004) · Journal of Inflammation · doi:10.1186/1476-9255-1-3 · Cited by 102
Yasunari, K., Maeda, K., Watanabe, T., Nakamura, M., Yoshikawa, J., & Asada, A. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.12.051 · Cited by 102
Inflammation may be a bridge connecting hypertension and atherosclerosis
Li, J., & Chen, J. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.10.016 · Cited by 101
Prunicki, M. M., Cauwenberghs, N., Lee, J., Zhou, X., Movassagh, H., Noth, E. M., Lurmann, F. W., Hammond, S. K., Balmes, J. R., Desai, M., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-83577-3 · Cited by 100
Fortuño, A., Oliván, S., Beloqui, Ó., José, G. S., Moreno, M. U., ez, J. D., & Zalba, G. (2004) · Journal of Hypertension · doi:10.1097/00004872-200411000-00020 · Cited by 99
Agarwal, D., Haque, M., Sriramula, S., Mariappan, N., Pariaut, R., & Francis, J. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.135459 · Cited by 98
Is hypertension an inflammatory disease?
Li, J., Fang, C., & Hui, R.-T. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.06.017 · Cited by 97
Inflammation in the pathophysiology of essential hypertension
Montecucco, F., Pende, A., Quercioli, A., & Mach, F. (2010) · Journal of Nephrology · doi:10.5301/jn.2010.4729 · Cited by 94
Macrophages under pressure: the role of macrophage polarization in hypertension
Harwani, S. C. (2017) · Translational research · doi:10.1016/j.trsl.2017.10.011 · Cited by 95
Brüünsgaard, H. (2006) · PubMed · Cited by 90
Yoshida, S., Takeuchi, T., Kotani, T., Yamamoto, N., Hata, K., Nagai, K., Shoda, T., Takai, S., Makino, S., & Hanafusa, T. (2013) · Journal of Human Hypertension · doi:10.1038/jhh.2013.80 · Cited by 87
Rahman, M. S., & Woollard, K. J. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-57613-8_7 · Cited by 87
José, G. S., Moreno, M. U., Oliván, S., Beloqui, Ó., Fortuño, A., Dı́ez, J., & Zalba, G. (2004) · Hypertension · doi:10.1161/01.hyp.0000134790.02026.e4 · Cited by 86
NADPH Oxidase-Mediated Oxidative Stress: Genetic Studies of the p22 phox Gene in Hypertension
Zalba, G., José, G. S., Moreno, M. U., Fortuño, A., & Díez, J. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.1327 · Cited by 86
Role of Adipokines in the Obesity???Inflammation Relationship: The Effect of Fat Removal
Esposito, K., Giugliano, G., Scuderi, N., & Giugliano, D. (2006) · Plastic & Reconstructive Surgery · doi:10.1097/01.prs.0000232281.49432.ce · Cited by 88
Carnagarin, R., Matthews, V. B., Zaldivia, M. T. K., Peter, K., & Schlaich, M. P. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14481 · Cited by 85
Androulakis, E. S., Tousoulis, D., Παπαγεωργίου, Ν., Tsioufis, C. P., Kallikazaros, I. E., & Stefanadis, C. (2009) · Cardiology in Review · doi:10.1097/crd.0b013e3181b18e03 · Cited by 83
Atherosclerosis and Coronary Artery Disease
Zaromitidou, M., Siasos, G., Παπαγεωργίου, Ν., Oikonomou, E. K., & Tousoulis, D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803312-8.00002-1 · Cited by 82
Interleukin-1β polymorphisms in Colombian patients with autoimmune rheumatic diseases
Camargo, J. F., Corréa, P., Castiblanco, J., & Anaya, J. (2004) · Genes and Immunity · doi:10.1038/sj.gene.6364133 · Cited by 78
Pivotal Roles of Monocytes/Macrophages in Stroke
Chiba, T., & Umegaki, K. (2013) · Mediators of Inflammation · doi:10.1155/2013/759103 · Cited by 81
Renal Denervation Reduces Monocyte Activation and Monocyte–Platelet Aggregate Formation
Zaldivia, M. T. K., Rivera, J., Hering, D., Marušić, P., Sata, Y., Lim, B., Eikelis, N., Lee, R., Lambert, G. W., Esler, M., et al. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.08373 · Cited by 78
Furumoto, T., Saito, N., Dong, J., Mikami, T., Fujii, S., & Kitabatake, A. (2002) · Hypertension Research · doi:10.1291/hypres.25.475 · Cited by 77
Shedding of TNF-α receptors, blood pressure, and insulin sensitivity in type 2 diabetes mellitus
Fernández‐Real, J. M., Lainez, B., Vendrell, J. J., Rigla, M., Castro, A., Peñarroja, G., Broch, M., Pérez, A., Richart, C., Engel, P., et al. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00444.2001 · Cited by 77
Liong, S., Oseghale, O., To, E. E., Brassington, K., Erlich, J. R., Luong, R., Liong, F., Brooks, R. D., Martin, C. M., O’Toole, S. A., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2006905117 · Cited by 76
Role of Angiotensin II Type 1 Receptor in Angiotensin II-Induced Cytokine Production in Macrophages
Guo, F., Chen, X., Wang, F., Liang, X., Sun, Y., & Wang, Y. (2011) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0073 · Cited by 71
Navarro‐González, J. F., Fernández, C. M., Gomez, M., Muros, M., López-Aguilar, C., & Garcı́a, J. G. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm674 · Cited by 71
Increased Transient Receptor Potential Channel TRPC3 Expression in Spontaneously Hypertensive Rats
Liu, D., Scholze, A., ZHU, Z., Kreutz, R. H., Wehland, M., Zidek, W., & Tepel, M. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2005.05.033 · Cited by 69
Glenn, C. L. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.13.1943 · Cited by 69
Transient receptor potential channels in essential hypertension
Liu, D., Scholze, A., Zhu, Z., Krueger, K., Thilo, F., Burkert, A., Streffer, K., Holz, S., Harteneck, C., Zidek, W., et al. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000226201.73065.14 · Cited by 68
C-reactive protein in hypertension: clinical significance and predictive value
Schillaci, G., & Pirro, M. (2006) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2006.05.001 · Cited by 68
An Update on Immune System Activation in the Pathogenesis of Hypertension
Ryan, M. J. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.00603 · Cited by 68
Interactions Between the Immune and the Renin–Angiotensin Systems in Hypertension
Rudemiller, N. P., & Crowley, S. D. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.06591 · Cited by 69
Zalba, G., Beloqui, Ó., José, G. S., Moreno, M. U., Fortuño, A., & Dı́ez, J. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000168411.72483.08 · Cited by 66
Monocytes/macrophages in hypertension
Hilgers, K. F. (2002) · Journal of Hypertension · doi:10.1097/00004872-200204000-00010 · Cited by 62
Associations Between Inflammation and Cognitive Function in African Americans and European Americans
Windham, B. G., Simpson, B. N., Lirette, S. T., Bridges, J. M., Bielak, L. F., Peyser, P. A., Kullo, I. J., Turner, S. T., Griswold, M. E., & Mosley, T. H. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13165 · Cited by 60
Arterial Hypertension Aggravates Innate Immune Responses after Experimental Stroke
Möller, K., Pösel, C., Kranz, A., Schulz, I., Scheibe, J., Didwischus, N., Boltze, J., Weise, G., & Wagner, D. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00461 · Cited by 58
Circulating monocytes: an appropriate model for bone-related study
Zhou, Y. G., Deng, H., & Shen, H. (2015) · Osteoporosis International · doi:10.1007/s00198-015-3250-7 · Cited by 58
Monocytes as immune targets in arterial hypertension
Wenzel, P. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14389 · Cited by 56
Peters, J. L., Kubzansky, L. D., Ikeda, A., Fang, S. C., Sparrow, D., Weisskopf, M. G., Wright, R. O., Vokonas, P., Hu, H., & Schwartz, J. D. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1103467 · Cited by 55
Pires, P. W., Girgla, S. S., McClain, J. L., Kaminski, N. E., van Rooijen, N., & Dorrance, A. M. (2013) · Microcirculation · doi:10.1111/micc.12064 · Cited by 56
Vascular Stress Signaling in Hypertension
Cicalese, S. M., da Silva, J. F., Priviero, F. B. M., Webb, R. C., Eguchi, S., & Tostes, R. C. (2021) · Circulation Research · doi:10.1161/circresaha.121.318053 · Cited by 54
Liu, D. Y., Thilo, F., Scholze, A., Wittstock, A., Zhao, Z. G., Harteneck, C., Zidek, W., Zhu, Z. M., & Tepel, M. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e32803cae2b · Cited by 54
Inflammation and oxidative stress in salt sensitive hypertension; The role of the NLRP3 inflammasome
Ertuğlu, L. A., Mutchler, A. P., Yu, J. D., & Kirabo, A. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1096296 · Cited by 53
Human monocyte subsets exhibit divergent angiotensin I-converting activity
Rutkowska-Zapała, M., Suski, M., Szatanek, R., Lenart, M., Węglarczyk, K., Olszanecki, R., Grodzicki, T. K., Strach, M., Gąsowski, J., & Siedlar, M. (2015) · Clinical & Experimental Immunology · doi:10.1111/cei.12612 · Cited by 53
Effects of sympathetic modulation in metabolic disease
Carnagarin, R., Lambert, G. W., Kiuchi, M. G., Nolde, J. M., Matthews, V. B., Eikelis, N., Lambert, É., & Schlaich, M. P. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14217 · Cited by 52
Innate immunity in CKD-associated vascular diseases
Zewinger, S., Schumann, T., Fliser, D., & Speer, T. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv358 · Cited by 51
Hypotension as a marker or mediator of perioperative organ injury: a narrative review
Ackland, G. L., & Abbott, T. E. F. (2022) · British Journal of Anaesthesia · doi:10.1016/j.bja.2022.01.012 · Cited by 53
Todorov, V., Völkl, S., Müller, M., Bohla, A., Klar, J., Kunz‐Schughart, L. A., Hehlgans, T., & Kurtz, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308697200 · Cited by 50
Tumor necrosis factor-α inhibits renin gene expression
Todorov, V., Müller, M., Schweda, F., & Kurtz, A. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00142.2002 · Cited by 50
Navarro‐González, J. F., Fernández, C. M., Muros, M., Jarque, A., Herrera, H., & Garcı́a, J. G. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e32830e2545 · Cited by 48
MDCO-216 Does Not Induce Adverse Immunostimulation, in Contrast to Its Predecessor ETC-216
Reijers, J. A. A., Kallend, D. G., Malone, K. E., Jukema, J. W., Wijngaard, P., Burggraaf, J., & Moerland, M. (2017) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-017-6746-x · Cited by 48
Zhao, S., Li, Q., Liu, L., Xu, Z., & Xiao, J. (2004) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.03.003 · Cited by 48
Innate Immune Cells and Hypertension: Neutrophils and Neutrophil Extracellular Traps (NETs)
McCarthy, C. G., Saha, P., Golonka, R. M., Wenceslau, C. F., Joe, B., & Vijay–Kumar, M. (2021) · Comprehensive physiology · doi:10.1002/cphy.c200020 · Cited by 48
Isoda, K., Akita, K., Kitamura, K., Sato-Okabayashi, Y., Kadoguchi, T., Isobe, S., Ohtomo, F., Sano, M., Shimada, K., Iwakura, Y., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.05.072 · Cited by 46
Sicard, P., Delemasure, S., Korandji, C., Grand, A. S.-L., Lauzier, B., Guilland, J.-C., Duvillard, L., Zeller, M., Cottin, Y., Vergely, C., et al. (2008) · Free Radical Research · doi:10.1080/10715760701885380 · Cited by 45
Harwani, S. C., Ratcliff, J. A., Sutterwala, F. S., Ballas, Z. K., Meyerholz, D. K., Chapleau, M. W., & Abboud, F. M. (2016) · Circulation Research · doi:10.1161/circresaha.116.309402 · Cited by 44
Salt-Sensitivity of Blood Pressure and Insulin Resistance
Ertuğlu, L. A., Elijovich, F., Laffer, C. L., & Kirabo, A. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.793924 · Cited by 44
Qian, X., Yin, T., Li, T., Kang, C., Guo, R., Sun, B., & Liu, C. (2012) · Inflammation · doi:10.1007/s10753-012-9464-3 · Cited by 44
Agarwal, D., Dange, R. B., Vila, J., Otamendi, A. J., & Francis, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052569 · Cited by 45
Ito, H., Ohshima, A., Tsuzuki, M., Ohto, N., Takao, K., Hijii, C., Yanagawa, M., Ogasawara, M., & Nishioka, K. (2001) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2001.03429.x · Cited by 43
The potential anti-inflammatory benefits of improving physical fitness in hypertension
Edwards, K. M., Ziegler, M. G., & Mills, P. J. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e328165ca67 · Cited by 43
Todorov, V., Völkl, S., Friedrich, J., Kunz‐Schughart, L. A., Hehlgans, T., Vermeulen, L., Haegeman, G., Schmitz, M. L., & Kurtz, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502968200 · Cited by 42
Hazan‐Halevy, I., Levy, T., Wolak, T., Lubarsky, I., Lévy, R., & Paran, E. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000170381.53955.68 · Cited by 42
Preactivated monocytes from hypertensive patients as a factor for atherosclerosis?
Dörffel, Y. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00674-2 · Cited by 42
Metadata
- Authors
- Dörffel, Y., Lätsch, C., Stuhlmüller, B., Schreiber, S., Scholze, S., Burmester, G. R., & Scholze, J.
- Affiliations
- From the Outpatient Clinics of Internal Medicine (Y.D., C.L., J.S.), and the Department of Rheumatology and Clinical Immunology (B.S., S. Scholze, G.R.B.), Charité University Hospital, Humboldt University, Berlin, and First Medical Department, Christian Albrecht University, Kiel, (S. Schreiber) Germany.
- Christian-Albrechts-Universität zu Kiel (DE)
- Venue
- Hypertension
- Published
- 1999-07
- Volume
- 34
- Issue
- 1
- Pages
- 113-117
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2169025417
- Cited by
- 262
- References
- 32
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 7 · 2023: 11 · 2022: 9 · 2021: 12 · 2020: 9 · 2019: 9 · 2018: 9 · 2017: 15 · 2016: 9 · 2015: 9 · 2014: 7 · 2013: 10 · 2012: 11
- FWCI
- 4.81
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Hypertension (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Keywords
- essential hypertension, peripheral blood monocytes, monocyte activation, inflammatory cytokines, angiotensin II, angiotensin II type 1 receptor, losartan, IL-1β, TNF-α, interleukin-6, lipopolysaccharide
- MeSH terms
- Adult, Aged, Angiotensin II, Cells, Cultured, Female, Humans, Hypertension, Interleukin-1, Lipopolysaccharides, Male, Middle Aged, Monocytes, Reference Values, Tumor Necrosis Factor-alpha, Interleukin-6, Cytokines, Reverse Transcriptase Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review